Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate effects on dopaminergic system development in ADHD
2010-023654-37Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate with Placebo (2 arms). Primary endpoints: Age-dependency of methylphenidate effects on dopaminergic system outgrowth by MRI and Age-dependency of methylphenidate effects on functional outcomes. Started Nov 2010; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2010-023654-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023654-37.